Segall Bryant & Hamill, LLC Viatris Inc Transaction History

Segall Bryant & Hamill, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$12.09 - $14.68 $192,122 - $233,279	-15,891 Closed	0 $0
Q3 2021 Nov 03, 2021	BUY	$13.25 - $15.13 $2,901 - $3,313	219 Added 1.4%	15,891 $215,000
Q2 2021 Aug 12, 2021	SELL	$12.97 - $16.15 $4,085 - $5,087	-315 Reduced 1.97%	15,672 $223,000
Q1 2021 May 13, 2021	BUY	$13.59 - $18.54 $217,263 - $296,398	15,987 New	15,987 $223,000

1,102

934M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $16.2B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Segall Bryant & Hamill, LLC, based on Form 13F filings with the SEC.

Stay updated on Segall Bryant & Hamill, LLC with notifications on news.